Effects of Dietary Fiber on Gastrointestinal Function
A Double-blind, Randomized, Crossover Trial to Assess the Gastrointestinal Tolerability of a Dietary Fiber Ingredient in Healthy Men and Women
1 other identifier
interventional
26
1 country
1
Brief Summary
The purpose of the study will be to assess the gastrointestinal effects of a dietary fiber in healthy, adult volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 14, 2011
CompletedFirst Posted
Study publicly available on registry
December 19, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedApril 21, 2016
December 1, 2011
1 year
December 14, 2011
April 20, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastrointestinal tolerability
Questionnaire to assess symptoms such as nausea, bloating, and flatulence
subjects will report weekly for 6 weeks
Secondary Outcomes (1)
Fecal output
subjects will collect fecal output for 12 days within a six-week period
Study Arms (3)
Dietary Fiber - Dose 1
EXPERIMENTALDietary fiber will be added to study foods
Dietary Fiber - Dose 2
EXPERIMENTALDietary fiber will be added to study foods
Control
ACTIVE COMPARATORStudy foods with no added fiber will be given
Interventions
A proprietary fiber will be given to subjects
Eligibility Criteria
You may qualify if:
- healthy men and women
- age 18 - 54 years
- BMI \< 30 kg/m2
You may not qualify if:
- presence of GI or other serious diseases known to affect GI function
- recent use of antibiotics
- very high fiber intake
- use of medications known to affect GI function
- presence of allergies to study foods
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Provident Clinical Research and Consulting Inc
Glen Ellyn, Illinois, 60137, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin Maki, PhD
Provident Clinical Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2011
First Posted
December 19, 2011
Study Start
December 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
April 21, 2016
Record last verified: 2011-12